bioRxivImmunology
Big Defensin ApBD1 from the scallop Argopecten purpuratus is an antimicrobial peptide which entraps bacteria through nanonets formation
Abstract
Antimicrobial peptides (AMPs) are ancient innate immune components. Big defensins is a family of AMPs found in a restricted number of animal phyla, in particular mollusks where they have highly diversified. Big defensins are composed of a highly hydrophobic N-terminal region and a C-terminal {beta}-defensin-like region, stabilized by three disulfide bridges. They have been shown to be active against both Gram-positive, Gram-negative bacteria and fungi. Antimicrobial aggregates called nanonets entrapping bacteria have been recently described as the mechanism of action of the Cg-BigDef1 from the oyster Crassostrea gigas. Specifically, the N-terminal domain of Cg-BigDef1 was identified as responsible of nanonet formation. In order to determine whether nanonets are specific to oyster Cg-BigDef1 or common to other big defensins outside this species, we assessed the potential entrapping of bacteria through nanonets of the big defensin from the scallop Argopecten purpuratus, namely ApBD1. Recombinant ApBD1 was produced as a fusion polypeptide which carried a N-terminal His6 tag, with a thrombin cleavage site before the mature peptide sequence and an unfolded C-terminal domain by mutating the last Cys to Arg. Activity of rApBD1 was assessed against the gram-positive bacteria Staphylococcus aureus SG511. rApBD1 inhibited bacterial growth. Moreover, strong immune staining of rApBD1 in numerous areas surrounding bacteria was observed. Overall, results suggest that rApBD1 entrap bacteria in peptide aggregates similar to those reported to Cg-BigDef1. This study demonstrates the conservation of nanonet formation across big defensins and supports further a role for the N-terminal domain in this conserved process.
- organism: mouse
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Antimicrobial peptides originating from expression libraries of Aurelia aurita and Mnemiopsis leidyi prevent biofilm formation of opportunistic pathogens
L. Ladewig, L. Gloy, … R. A. Schmitz·bioRxiv·Mar 2, 2023
- The Nematode Antimicrobial Peptidome: a novel opportunity for parasite control?
Allister Irvine, Sharon Huws, … Angela Mousley·bioRxiv·Sep 26, 2022
- Requirement of the antimicrobial peptide CRAMP for macrophages to eliminate phagocytosed E. coli through an autophagy pathway
K. Chen, T. Yoshimura, … J.-m. Wang·bioRxiv·Jul 23, 2020
- The antimicrobial peptide TAT-RasGAP317-326 inhibits the formation and the expansion of bacterial biofilms in vitro
T. Heinonen, S. Hargraves, … N. Jacquier·bioRxiv·Sep 29, 2020
- Novel action of proline-rich antimicrobial peptides Api88, Api137, Onc72 and Onc112 against Pseudomonas aeruginosa and Escherichia coli in ion-rich environments.
Namfon Pantarat, Daniel Knappe, … Neil Martin O’brien-simpson·bioRxiv·May 9, 2025
- Human Histone Fragments Display Antibacterial Properties against Pseudomonas aeruginosa
Nourice Jaber, Angela Di Somma, … Barbara Spellerberg·Frontiers in ImmunologyPeer-reviewed·Aug 12, 2026